Fluocortolone
![]() | |
| Clinical data | |
|---|---|
| Other names | (6S,8S,9R,10S,11S,13S,14S,16R,17S)-6-fluoro-11-hydroxy-17-(2-hydroxyacetyl)-10,13,16-trimethyl-6,7,8,9,11,12,14,15,16,17-decahydrocyclopenta[a]phenanthren-3-one |
| Routes of administration | Ointment, suppositories |
| ATC code | |
| Identifiers | |
| |
| CAS Number | |
| PubChem CID | |
| DrugBank | |
| ChemSpider | |
| UNII | |
| KEGG | |
| ChEMBL | |
| CompTox Dashboard (EPA) | |
| ECHA InfoCard | 100.005.284 |
| Chemical and physical data | |
| Formula | C22H29FO4 |
| Molar mass | 376.468 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
| | |
Fluocortolone is a glucocorticoid[1] used in the treatment of several conditions, including hemorrhoids.
It is similar to fluocortin, but with one less carbonyl group.
See also
References
- ^ Munro DD, Wilson HT, Rhodes EL (November 1967). "Comparison of betamethasone 17-valerate ointment with fluocortolone and fluocortolone caproate ointment". British Medical Journal. 4 (5574): 275–6. doi:10.1136/bmj.4.5574.275. PMC 1748932. PMID 6054003.
